Literature DB >> 9629927

Alterations in the expression of P2X1 receptors in failing and nondiseased human atria.

D Berry1, M Yao, J A Barden, V J Balcar, M A Hansen, M R Bennett, A Keogh, C G dos Remedios.   

Abstract

This is the first report of the analysis of the ATP-specific P2X1 receptor subunit in human hearts. We have examined homogenate samples of human left atria for the presence of P2X1 receptors using Western blots. Anti-P2X1 immunoreactivity was detected in populations of nondiseased atria as well as in atria from explanted hearts from patients with terminally failing heart conditions such as dilated cardiomyopathy. At least three groups of P2X1 immunoreactive proteins were detected in the Western blots with approximate molecular mass values of 50, 70, and 160 kDa. We report changes in expression of their 50 and 70 kDa components. These changes may be related to the type of deficit in these hearts since the changes have been observed in hearts with decreased ejection fractions characteristic of dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629927     DOI: 10.1002/elps.1150190542

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 2.  Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective.

Authors:  C G Dos Remedios; A Li; S Lal
Journal:  Biophys Rev       Date:  2018-07-18

Review 3.  The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.

Authors:  W Linke; C G Dos Remedios; S P Lal; A Li; J McNamara; A Keogh; P S Macdonald; R Cooke; E Ehler; R Knöll; S B Marston; J Stelzer; H Granzier; C Bezzina; S van Dijk; F De Man; G J M Stienen; J Odeberg; F Pontén; J van der Velden
Journal:  Biophys Rev       Date:  2017-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.